2007
Sarcoidosis Mimicking Metastatic Breast Cancer
Tolaney SM, Colson YL, Gill RR, Schulte S, Duggan MM, Shulman LN, Winer EP. Sarcoidosis Mimicking Metastatic Breast Cancer. Clinical Breast Cancer 2007, 7: 804-810. PMID: 18021484, DOI: 10.3816/cbc.2007.n.044.Peer-Reviewed Original ResearchInvasive breast cancer.
Carlson RW, Anderson BO, Burstein HJ, Carter WB, Edge SB, Farrar WB, Goldstein LJ, Gradishar WJ, Hayes DF, Hudis CA, Jahanzeb M, Ljung BM, Kiel K, Marks LB, McCormick B, Nabell LM, Pierce LJ, Reed EC, Silver SM, Smith ML, Somlo G, Theriault RL, Ward JH, Winer EP, Wolff AC. Invasive breast cancer. Journal Of The National Comprehensive Cancer Network 2007, 5: 246-312. PMID: 17439758, DOI: 10.6004/jnccn.2007.0025.Peer-Reviewed Original ResearchConceptsInvasive breast cancerBreast cancerBreast cancer mortalityAmerican Cancer SocietyMore effective treatmentsCommon malignancyCancer mortalityCancer deathLung cancerCancer SocietyEffective treatmentNew casesCancerEarly detectionUnited StatesTreatmentGuidelinesMalignancyMortalityIncidenceDiseaseDiagnosisWomen
2005
Breast cancer.
Carlson RW, Anderson BO, Burstein HJ, Cox CE, Edge SB, Farrar WB, Goldstein LJ, Gradishar WJ, Hayes DF, Hudis C, Jahanzeb M, Ljung BM, Marks LB, McCormick B, Nabell LM, Pierce LJ, Reed EC, Silver SM, Smith ML, Somlo G, Theriault RL, Ward JH, Winer EP, Wolff AC. Breast cancer. Journal Of The National Comprehensive Cancer Network 2005, 3: 238-89. PMID: 16002000, DOI: 10.6004/jnccn.2005.0015.Peer-Reviewed Original Research
2004
New targets for therapy in breast cancer: Small molecule tyrosine kinase inhibitors
Lin NU, Winer EP. New targets for therapy in breast cancer: Small molecule tyrosine kinase inhibitors. Breast Cancer Research 2004, 6: 204. PMID: 15318926, PMCID: PMC549180, DOI: 10.1186/bcr919.Peer-Reviewed Original ResearchConceptsTyrosine kinase inhibitorsBreast cancerSmall molecule tyrosine kinase inhibitorsMolecule tyrosine kinase inhibitorsKinase inhibitorsErbB familyPredictive markerClinical dataReceptor signal transduction pathwaySmall molecule inhibitorsTumor sensitivityTumor growthReceptor tyrosine kinasesNew targetsCritical pathwaysMolecule inhibitorsCancerPotential crosstalkInhibitorsTyrosine kinaseSignal transduction pathwaysRational combinationBroad spectrumTransduction pathwaysMalignancy
1998
Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk.
Frank TS, Manley SA, Olopade OI, Cummings S, Garber JE, Bernhardt B, Antman K, Russo D, Wood ME, Mullineau L, Isaacs C, Peshkin B, Buys S, Venne V, Rowley PT, Loader S, Offit K, Robson M, Hampel H, Brener D, Winer EP, Clark S, Weber B, Strong LC, Thomas A. Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk. Journal Of Clinical Oncology 1998, 16: 2417-25. PMID: 9667259, DOI: 10.1200/jco.1998.16.7.2417.Peer-Reviewed Original Research
1994
Quality of life after bone marrow transplantation.
Winer EP, Sutton LM. Quality of life after bone marrow transplantation. Oncology 1994, 8: 19-27; discussion 27-8, 31. PMID: 8123445.Peer-Reviewed Original ResearchConceptsBone marrow transplantationQuality of lifeMarrow transplantationAutologous bone marrow transplantationVariety of malignanciesTransplant settingNonmalignant disordersAutologous transplantationPsychosocial functioningTransplantationAdverse effectsVocational difficultiesPhysical toxicityTreatmentFuture qualityPatientsMalignancyLife research